| Financial Year |
March 31 2023 |
| Monetary Funds |
545,415,157.82 |
| Held-for-trading Financial Assets |
1,997,316.64 |
| Notes Receivable |
-- |
| Accounts Receivable |
90,842,725.09 |
| Advances to Suppliers |
200,571,106.06 |
| Other Receivables |
82,942,526.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,795,334.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,490,306.38 |
| Total Current Assets |
1,119,007,095.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
99,813,001.75 |
| Investment Properties |
-- |
| Fixed Assetes |
21,701,760.13 |
| Under-construction Projects |
152,996,529.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,100,431.40 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
97,466.07 |
| Deferred Income Tax Assets |
328,371,864.23 |
| Other Non-Current Assets |
21,567,705.56 |
| Sub-Total of Non-Current Assets |
1,042,562,041.92 |
| Total Assets |
2,161,569,137.83 |
| Short-Term Loans |
488,974,601.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
261,521,610.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,291,763.31 |
| Taxes Payable |
10,473,969.24 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
611,244,050.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
48,484,436.88 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,662,066,403.07 |
| Long-term Loans |
44,421,300.15 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
308,289.31 |
| Special Payable |
-- |
| Estimatied Liabilities |
5,764,105.00 |
| Deferred Income Tax Liabilities |
3,142,374.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
53,636,068.97 |
| Total Liabilities |
1,715,702,472.04 |
| Paid-In Capital(Or Share Stock) |
982,715,033.00 |
| Capital Surplus |
1,211,516,804.64 |
| Surplus Reserve |
63,914,667.79 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,324,145,053.05 |
| Minority Stockholder's Interest |
-237,526,785.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
683,393,451.21 |
| Owner's Equity（Stockholder's Equity） |
445,866,665.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,161,569,137.83 |
